Search
for
Sort by
Research 331–360 of 1000+
- The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Hair Loss as a Late Complication of Multisystem Inflammatory Syndrome in Children
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
- Long COVID? What is that?
- Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
- Short- and mid-term outcomes of multisystem inflammatory syndrome in children: a longitudinal prospective single-center cohort study
- Coronavirus Infection and Cholesterol Metabolism
- Clinical course of alopecia after COVID-19
- Rehabilitation therapy for a severe case of coronavirus disease 2019: a case report
- Reconnecting
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
- Faculty Opinions recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”.
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Skin disorders associated with the COVID‐19 pandemic: A review